Drawing for SYNTHEALL

USPTO serial 79302417

SYNTHEALL

Reviewed by CopyMark Law Group

Reg. 6703480Status 700Registered
Filing date
Status date
Registration date
Apr 19, 2022
Examiner
BLANE, SUZANNE
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with SYNTHEALL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Colleen Flynn Goss

Colleen Flynn Goss Fay Sharpe LLP1228 Euclid AvenueThe Halle Building, 5th FloorCleveland, OH 44115

Goods and services

ClassDescriptionStatusFirst use
001Alkaloids for industrial purposes; acids, namely boracic acid, carbonic acid; alkalies; protein in raw material form for scientific and medical research; chemical additives for insecticides; unprocessed artificial synthetic resinsACTIVE—
005Medicines for human purposes, namely for the treatment of diabetes, sinus infection; bacteriological preparations for medical and veterinary use; raw material medicine, namely miconazole nitrate for use in the manufacture of medicines, namely anti-allergic medicines, and prescription and non-prescription medicines for the prevention and treatment of bacterial, dermatological and gynecological diseases; pharmaceutical preparations, namely for the treatment of dermatological and gastro-intestinal disease; chemical and pharmaceutical preparations, namely for the treatment of gynecological disease; biological preparations for medical purposes, namely for the treatment of cancer; chemical preparations for medical purposes, namely for the treatment of respiratory disease; chemical preparations for pharmaceutical purposes, namely iodine, bromineACTIVE—
040Processing and handling of chemical reagents, namely drying, filtering and grinding chemical reagents; processing of medicinal materials, namely custom manufacturing of prescription and non-prescription medicines for the prevention and treatment of dermatological and gastro-intestinal diseasesACTIVE—
042Technical research in the field of pharmaceuticals; research and development for others in the field of medicine; chemical analysis; chemistry services, namely researching of production methods for manufacturing or transforming the substance in the laboratory and mass produced in factories; chemical research; biological researchACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 17, 2022FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Sep 1, 2022XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Sep 1, 2022XXCRGENERIC MADRID TRANSACTION CREATED—
Jul 19, 2022FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jul 8, 2022RNWLINTERNATIONAL REGISTRATION RENEWED—
Apr 19, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 1, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 1, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 29, 2022GPNXNOTIFICATION PROCESSED BY IB—
Jan 12, 2022OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jan 12, 2022OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jan 12, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 29, 2021PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Dec 29, 2021ALIEASSIGNED TO LIE—
Dec 27, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 1, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 30, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 30, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 27, 2021RFNTREFUSAL PROCESSED BY IB—
Jun 1, 2021RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jun 1, 2021RFRRREFUSAL PROCESSED BY MPU—
May 29, 2021RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
May 28, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 28, 2021DOCKASSIGNED TO EXAMINER—
Jan 23, 2021MAFRAPPLICATION FILING RECEIPT MAILED—
Jan 19, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 14, 2021SDRCSN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB—

Frequently asked questions

Related guidance